You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Patent: 9,931,380

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 9,931,380

Title:	Medicament for treating olfaction disorder
Abstract:	The object of the present invention is to provide an olfactory disturbance therapeutic agent that is effective in repairing or regenerating olfactory epithelium that suffered damages such as scratches and can be administered for a long time. The object of the present invention is achieved by an olfactory disturbance therapeutic agent including at least one active ingredient that is selected from among a group consisting of insulin, insulin analogs, and insulin secretagogues. Preferably, the olfactory disturbance therapeutic agent is used for people with olfactory disturbance who have, or are at risk of having, impaired insulin secretion or insulin resistance, or for people who could suffer an iatrogenic increase in blood sugar level or a disturbance in a balance of adrenocortical hormone stemming from a long-term use of steroid as olfactory disturbance treatment.
Inventor(s):	Kuboki; Akihito (Tokyo, JP), Kikuta; Shu (Tokyo, JP)
Assignee:
Application Number:	15/046,858
Patent Claims:	see list of patent claims

Details for Patent 9,931,380

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Eli Lilly And Company	HUMALOG	insulin lispro	Injection	020563	06/14/1996	⤷ Try a Trial	2035-02-19
Eli Lilly And Company	HUMALOG	insulin lispro	Injection	020563	08/06/1998	⤷ Try a Trial	2035-02-19
Eli Lilly And Company	HUMALOG	insulin lispro	Injection	020563	09/06/2007	⤷ Try a Trial	2035-02-19
Eli Lilly And Company	HUMALOG	insulin lispro	Injection	020563	06/06/2017	⤷ Try a Trial	2035-02-19
Eli Lilly And Company	HUMALOG	insulin lispro	Injection	020563	11/15/2019	⤷ Try a Trial	2035-02-19
Sanofi-aventis U.s. Llc	LANTUS	insulin glargine	Injection	021081	04/20/2000	⤷ Try a Trial	2035-02-19
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.